PerkinElmer has announced its acquisition of a line of Dynamic
Mechanical Analysis (DMA) products from UK-based firm Triton
Technology in its latest move following a busy year of purchases
during 2006.
LAB Research has completed a $12m facility expansion in Canada that
will increase its preclinical testing services capacity at the site
by 40 per cent.
A new radio frequency identification (RFID) tag for
temperature-monitoring purposes has been developed for
pharmaceutical products during transportation, where fluctuations
in temperature can alert the logistics chain of impending...
The pharmaceutical industry's first fully portable drug
anti-counterfeiting device will be presented in Baltimore later
this month at IFPAC, the International Forum on Process Analytical
Chemistry.
A US government report has warned that the pharmaceutical industry
is not producing enough new drugs despite spending more on research
and development.
Shares in Telik plummeted after they reported their most advanced
drug candidate failed three clinical trials, leaving analysts
asking why they did not find out sooner.
The Chinese government has announced plans to consolidate their
outsourcing industry in an effort to capture business from other
developing countries such as India.
US drug packaging manufacturer Brady has bought a Brazilian label
maker in a bid to expand its operations not only in Brazil but
throughout Latin America - an area considered by analysts to have a
great business potential.
Icelandic pharmaceutical Actavis has snapped up an Indian
manufacturing plant in a move to take advantage of lower
manufacturing costs for exports to the US and Europe.
A number of executives and technical staff at small to medium size
pharmaceutical firms are unaware of how to use their resources
effectively to comply with new EMEA guidelines, designed to
minimise the environmental impact of compounds,...
Giant drug maker Eli Lilly has confirmed that it will be closing
its manufacturing facility in Basingstoke, England, resulting in
$85m to $95m in restructuring costs for the company.
Quintiles has formed a new alliance with a hospital near its
headquarters in North Carolina, from where it has begun running
clinical trials on experimental drugs.
Pfizer has entered a capacity expansion phase, to meet requirements
of global manufacturing of Genotropin (somatropin), a top-selling
human growth hormone.
Analytical laboratory LGC has set up an initiative to develop a new
approach to training for analysts working in molecular
laboratories, with a novel e-learning tool.
The UK's Department of Trade and Industry (DTI) has pledged its
support to an ultrasound spectroscopy project conducted by LGC, to
evaluate its potential as a Process Analytical Tool (PAT) for
non-destructive testing, real time...
German biotech company MediGene and Sanofi Pasteur have signed a
deal to develop new monoclonal T cell receptors that the vaccine
maker will use to develop and validate vaccines more efficiently.
Ciphergen has hired contract research organization (CRO)
PrecisionMed to help it with upcoming clinical trials for its
experimental ovarian cancer tests.
Specialty pharmaceutical company CyDex has been boosted by the news
that an intramuscular injection formulation of schizophrenia drug
Abilify, which makes use of its Captisol solubility technology has
been launched in the USA.
NNE and Fresenius ProServe yesterday announced they had reached an
agreement by which NNE will acquire Fresenius' subsidiary,
engineering company Pharmaplan GmbH.
A breakthrough in diabetes research has finally let scientists
answer the elusive question of what causes the disease, enabling
them to develop to a new treatment that reverses its effects.
Fluidigm has launched its digital PCR technology, allowing
scientists to analyse a single DNA template, which will give them
the opportunity to detect cancer much earlier.
Crucell yesterday announced it had received the first orders from
US-headquartered Wyeth Biotech. The order represents the first move
following the finalisation of the contract manufacturing agreement
between the two companies at...
Innovative, non-invasive new ways of delivering insulin are poised
to transform diabetes management, despite concerns about their
safety and efficacy, according to new research.
Pharma company Medichem has announced it has passed a US Food and
Drug Administration (FDA) inspection without any problem for the
third consecutive time.
Researchers have discovered that using nanotechnology could help
reduce fatalities from drug overdoses, as nanoparticles can act as
potential antidotes.
Medicated chewing gum company Fertin Pharma has announced a
collaboration with the US Army Dental Research and Trauma
Detachment (USADRT) on the first antimicrobial chewing gum to lower
incidences of disease and non-battle related...
A UK based firm aims to take up the fight against drug
counterfeiters with its innovative imaging and spectroscopy
products. TeraView says its technology could aid regulators and law
enforcement agencies screen for potentially lethal...
In the next one to two years there will be a trend towards
significant reductions in clinical outsourcing/contract research
organisation (CRO) budgets in the majority of biopharma firms,
reveals a recent industry survey.
Solvay has contracted Novasep to provide synthesis of two active
pharmaceutical ingredients, following Novasep's decision to combine
synthesis and processing expertise.
The once hyped antisense sector of the pharmaceutical industry has
again proved a disappointment after one drug in development was
refused approval and another was scrapped.
Dr Reddy's Laboratories has boosted its ability to serve Western
pharmaceutical markets with an increase in its manufacturing
capacity for drug formulations.
MDS has been heavily impacted by a US Food and Drug Administration
procedural review of its bioanalytical operations, but still
managed to report quarterly earnings of C$53m (€35m).
Pharma company Shire has agreed with European regulators on
labelling information for its ulcerative colitis drug Mezavant, a
further step in the firm's ambition to capture more of the $1.6bn
(€1.2bn) mesalazine market through...
Drug delivery company MonoSolRx has announced it has received a
$38m (€29m) funding from an investment group, illustrating the
appeal of the company's dissolving film technology.
The race to find the next generation of treatments that prevent the
formation of potentially fatal blood clots heated up when
Boehringer Ingelheim announced positive Phase III trial results.